Glaukos Corporation | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Glaukos Corporation is an ophthalmic medical device and pharmaceutical company dedicated to developing innovative therapies for eye care, with a strong emphasis on glaucoma treatment and corneal health. Originally founded in 1998 in Laguna Hills, California, and now headquartered in Aliso Viejo, the company has significantly advanced the ophthalmic market through pioneering work in Micro-Invasive Glaucoma Surgery (MIGS).

The organization is recognized for its iStent technology, the first trabecular micro-bypass glaucoma stent approved by the FDA. Its portfolio includes Epioxa™, an ophthalmic solution for eye care treatment, and has grown through acquisitions such as Avedro for corneal health and DOSE Medical Corporation for retinal programs. With operations in 17 countries and comprehensive Medicare coverage, Glaukos is committed to expanding patient access and advancing treatment options across the globe.